Your browser doesn't support javascript.
loading
Editorial: How Will Aducanumab Approval Impact AD Research?
Weiner, M W; Aisen, P S; Beckett, L A; Green, R C; Jagust, W; Morris, J C; Okonkwo, O; Perrin, R J; Petersen, R C; Rivera Mindt, M; Saykin, A J; Shaw, L M; Toga, A W; Trojanowski, J Q.
Affiliation
  • Weiner MW; Michael W. Weiner, NCIRE, 4150 Clement St, San Francisco, CA 94121, USA. E-mail address: michael.weiner@ucsf.edu.
J Prev Alzheimers Dis ; 8(4): 391-392, 2021.
Article in En | MEDLINE | ID: mdl-34585209

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Drug Approval / Alzheimer Disease / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Drug Approval / Alzheimer Disease / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2021 Document type: Article